Element Labs
Series A in 2025
Element Labs develops AI processors for inference.
Home First Finance Company
Post in 2025
Home First Finance Company specializes in providing housing loans for buyers of affordable homes priced between Rs. 5 lakhs and Rs. 30 lakhs. It caters to first-time buyers who may have queries about the home purchase process, eligibility, documentation, repayment, ownership, registration, and other related aspects.
Nuro, Inc. is a technology company based in Mountain View, California, that specializes in the development of self-driving vehicles specifically designed for local goods transportation. Incorporated in 2016, Nuro aims to transform local commerce through its fleet of fully autonomous, electric vehicles that facilitate the delivery of a wide range of products, including food and pharmaceuticals. By enabling retailers to efficiently and safely deliver goods to customers, Nuro enhances the convenience of local commerce and meets the growing demand for autonomous delivery solutions.
Plaid
Venture Round in 2025
Plaid is a technology platform that provides APIs and developer tools to connect consumer bank accounts and financial data with applications. It enables developers to build modern financial services by offering infrastructure and intelligence tools that allow access to transactions, authentication for bank accounts, identity verification, real-time balances, asset verification, and income data. Its products include Transactions, Auth, Identity, Balance, Assets, and Income, supporting personal finance, consumer payments, lending, banking and brokerage, and business finance solutions. Plaid serves developers from startups to large financial institutions, helping democratize financial services with a developer-friendly experience. The company was founded in 2012 and is headquartered in San Francisco, California.
Runway, established in 2018, specializes in applied AI research and development. It offers an innovative video editing platform for professionals, utilizing AI-powered tools that enable intuitive manipulation and creation of visual content through text-based commands.
Retym is a startup focused on semiconductor technology. It aims to revolutionize the data center and telecommunications industries through its innovative solutions. The company's team comprises experienced ASIC designers, optical communications experts, and seasoned investors.
HeartFlow
Convertible Note in 2025
HeartFlow specializes in precision heart care, offering a non-invasive solution for diagnosing coronary artery disease. Its proprietary HeartFlow FFRCT Analysis uses artificial intelligence to create a personalized 3D model of the heart, enabling clinicians to evaluate blood flow and determine optimal treatment. Commercially available in the United States, UK, Canada, Europe, and Japan.
Capital Markets Gateway
Series C in 2025
Capital Markets Gateway Inc. is a financial technology firm that specializes in modernizing the equity capital markets. Based in Chicago, Illinois, with additional locations in New York and Seattle, CMG offers a platform that provides real-time information and analytics to investors, underwriters, and issuers. Founded in 2015 and officially launched in 2017 by a team of experienced professionals, the platform enhances transparency and workflow efficiencies in capital raising activities. It enables users to monitor the capital raising landscape, conduct due diligence, and make informed investment decisions while facilitating collaboration between stakeholders. Currently, CMG's platform is utilized by over 100 buy-side firms and 10 investment banks, supporting a substantial amount of assets under management.
Celestial AI
Series C in 2025
Celestial AI is a prominent artificial intelligence company that provides an advanced platform for users to efficiently create images, text, and presentations. Utilizing cutting-edge computer vision algorithms and natural language processing, the platform produces high-quality visual and textual content. Its intuitive design, combined with innovative features, facilitates easy content creation. Moreover, Celestial AI emphasizes intelligent data integration and prioritizes security, ensuring that users achieve impressive and reliable results.
Anthropic
Series E in 2025
Anthropic is an AI research company specializing in the safety of artificial intelligence systems. Its work spans natural language processing, human feedback integration, scaling laws, reinforcement learning, code generation, and interpretability. The company's flagship product is Claude, an AI assistant designed for various tasks. Anthropic develops AI systems that emphasize safety, transparency, and alignment with human values.
Amaero International
Post in 2025
Amaero International manufactures high-temperature metal powders and specialty powders, and uses gas atomization and hot isostatic pressing to produce refractory, titanium, and other alloy powders. It applies laser-based additive manufacturing to produce large-format, complex metal components and provides PM-HIP manufacturing of large near-net-shape parts with forged-equivalent properties. The company serves defense, aerospace, space, energy, and medical sectors and supports customers with research and development, contract manufacturing, tooling, equipment and consumables, as well as training and maintenance services. It collaborates with academic institutions, including a strategic partnership with the University of Adelaide to advance additive manufacturing in South Australia. Headquartered in Notting Hill, Australia, Amaero International aims to improve supply chain resilience for large-scale components through its powder and additive manufacturing capabilities.
Saluda Medical
Venture Round in 2025
Saluda Medical is a medical device company specializing in closed-loop neuromodulation therapies for chronic neurological conditions. Founded in 2010 and headquartered in Australia, the company develops innovative devices like Evoke, designed to optimize neural stimulation based on real-time feedback.
Tenstorrent
Series D in 2024
Tenstorrent Inc. is a technology company based in Toronto, Canada, with an additional office in Austin, Texas, founded in 2016. The company specializes in the development and manufacturing of application-specific integrated circuits (ASICs) tailored for machine learning and data processing tasks. Its hardware architecture is designed to support a range of applications, from battery-powered Internet of Things (IoT) devices to large-scale cloud servers, providing scalable solutions for deep learning. Tenstorrent's offerings enable developers and researchers in the artificial intelligence sector to enhance computational performance and adapt algorithms effectively, positioning the company as a key player in advancing AI technology.
Boosted.ai
Venture Round in 2024
Boosted.ai is an artificial intelligence company focused on improving portfolio management for the financial industry through distributed machine learning. Its flagship platform, Boosted Insights, enables portfolio managers to utilize advanced quantitative investing techniques without the need for coding or a data science background. The company develops machine learning software that enhances the investment decision-making process by conducting deep analyses of market data. By automating and simplifying complex tasks, Boosted.ai makes sophisticated investment tools accessible to all investment professionals, empowering them to achieve higher returns.
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
CoreWeave
Secondary Market in 2024
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.
Beta Technologies
Series C in 2024
Beta Technologies designs and develops electric aircraft and related systems, including propulsion, energy storage, and flight control technologies, with a focus on clean aviation. It builds integrated solutions to enable scalable electric flight, including charging infrastructure and pilot training tools for cargo, medical, passenger, and defense applications, and supports a self-sufficient eVTOL ecosystem that aims to improve access to vertical mobility for logistics and healthcare transport.
Crusoe Energy Systems
Series D in 2024
Crusoe Energy Systems Inc., based in Denver, Colorado, develops innovative technology and solutions aimed at addressing operational, environmental, and regulatory challenges in the oil and gas sector. Founded in 2018, the company specializes in its Digital Flare Mitigation solution, which allows upstream operators without pipeline access to convert wasted natural gas into electricity for energy-intensive computing. This service not only helps oil and gas producers reduce routine flaring of natural gas but also assists them in achieving regulatory compliance and maintaining production levels amid increasing regulations and pipeline constraints. Crusoe Energy Systems is committed to creating solutions that benefit the environment, local communities, and energy producers alike.
Lightmatter
Series D in 2024
Founded in 2017 and based in Boston, Lightmatter is an artificial intelligence hardware company that specializes in integrated optical technology. It designs photonic chips to enable data processing and communication through light signals, aiming to improve efficiency and scalability for AI data centers.
Wolfspeed is a leading manufacturer specializing in wide bandgap semiconductors, particularly silicon carbide (SiC) and gallium nitride (GaN) materials and devices. The company plays a crucial role in the transformation of the semiconductor industry, supporting the transition to electric vehicles, the deployment of faster 5G networks, and advancements in renewable energy and energy storage systems. Wolfspeed offers a range of products designed for power and radio-frequency applications, including use in transportation, power supplies, inverters, and wireless systems. With a workforce of over 550 skilled employees, the company boasts a robust intellectual property portfolio of approximately 2,000 patents and patent applications. Its operations are primarily based in Europe, with additional revenue derived from the United States, China, Hong Kong, and other regions.
City Therapeutics
Series A in 2024
City Therapeutics is a biopharmaceutical company specializing in the development of next-generation small-interfering RNAs (siRNAs) to enhance RNA interference (RNAi) therapies. The company's pipeline comprises innovative RNAi therapeutics targeting diverse disease indications. City Therapeutics aims to improve and expand RNAi technology to achieve better patient outcomes, led by a team of experienced scientists and industry professionals committed to advancing the field of RNA interference.
Triveni Bio
Series B in 2024
Triveni Bio is a biotechnology company specializing in the development of novel antibody therapies for immunological and inflammatory disorders. The company employs a genetics-driven precision medicine approach to identify patients most likely to respond to its treatments, aiming to accelerate drug development and improve the effectiveness and safety of therapies.
OpenAI
Venture Round in 2024
OpenAI is an AI research and deployment company that develops general-purpose artificial intelligence technologies and applies them to real-world problems. It conducts machine learning research and builds systems such as large-scale language models, multimodal input handling, and code generation to support automation, data analysis, content generation, and interactive problem solving across industries including technology, healthcare, and education. The organization offers platforms and APIs that enable enterprises, developers, and researchers to build, test, and deploy intelligent systems, with plug-in extensibility and ongoing model updates to improve performance and safety.
PNB Housing Finance
Post in 2024
PNB Housing Finance Limited is a housing finance company based in New Delhi, India, established in 1988. The company specializes in providing a variety of loans, including housing loans for the purchase, construction, repair, and renovation of residential and commercial properties. It also offers loans against property, loans for the purchase of residential plots, and financing for commercial spaces. PNB Housing Finance caters to different customer segments, including non-resident Indians and individuals from economically weaker sections and lower to middle-income groups through various schemes. In addition to home loans, the company provides non-home loans, such as mortgage loans for residential and commercial properties, lease rental discounting loans, and financing for real estate developers. PNB Housing Finance generates revenue primarily through interest income and fees from its diverse lending services.
Anduril Industries
Series F in 2024
Anduril Industries is a defense technology company that designs, develops, and deploys hardware and software to address national security challenges for the United States and its allies. It offers the Lattice Platform, an AI-based system that fuses real-time data from computer vision, machine learning, and mesh networking into a single autonomous operating picture; Sentry Tower, which integrates data across the electromagnetic spectrum; Ghost sUAS, an unmanned autonomous, man-portable drone capable of performing missions with limited human intervention; and Anvil sUAS, a precision kinetic intercept that autonomously navigates to counter potential drone threats with visual verification by a human operator. Founded in 2017, Anduril is based in Irvine, California, with additional offices in Orange County, California; Washington, D.C.; and Seattle, Washington.
Applied Intuition
Secondary Market in 2024
Applied Intuition develops software infrastructure to safely develop, test, and deploy autonomous vehicles at scale. Founded in 2017 and based in Sunnyvale, California, it maintains offices in Silicon Valley and Detroit. The company offers an autonomous vehicle platform for simulation, validation, and deployment of advanced driver-assistance and automated driving systems, integrating AI-powered development tools with modular software architecture to help automotive manufacturers and mobility companies optimize autonomous system performance and streamline integration across diverse vehicle types and operating environments.
Waymo is a self-driving technology company dedicated to improving mobility. Established from Google's labs in 2009, Waymo aims to make transportation safer and easier by developing advanced software and sensor technologies. The company achieved the world's first fully self-driven trip on public roads in 2015, using cars without steering wheels or pedals. Today, Waymo continues to refine its technology through extensive simulation testing and real-world driving across multiple cities.
Frore Systems
Series C in 2024
Frore Systems is a technology company based in San Jose, California, specializing in thermal management solutions for consumer devices. The company develops advanced cooling chips, specifically the AirJet® Mini and AirJet® Pro, which utilize piezoelectric MEMS technology to provide efficient and silent heat dissipation. These active cooling solutions significantly enhance device performance by outperforming traditional fan-based systems. With additional offices in Taiwan and South Korea, Frore Systems is positioned to impact the computing industry by enabling manufacturers to improve the thermal efficiency and performance of their devices.
CoreWeave
Series C in 2024
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.
PSP Projects is a multidisciplinary construction company in India offering a diversified range of construction and allied services across industrial, institutional, government, government residential, and residential projects. It provides services across the construction value chain, from planning and design to construction and post-construction activities, and operates in a single segment focused on construction project activities, with revenue generated primarily in India.
Vodafone Idea
Post in 2024
Vodafone Idea is a prominent Indian telecommunications operator that offers comprehensive voice and data services across the country. Established through the merger of Vodafone India and Idea Cellular, the company primarily focuses on mobility services, which account for the majority of its revenue. It operates a vast telecommunications infrastructure, including fiber networks and mobile towers, to support its service offerings. Vodafone Idea primarily generates its revenue from the Indian market, positioning itself as a key player in the country's telecommunications sector. The company's operations encompass various aspects of information technology and telecommunications, catering to a diverse customer base.
SiMa.ai is a software-centric, embedded edge machine learning system-on-chip company that develops a complete MLSoC platform combining hardware and software to enable high-performance, low-power machine learning inference on embedded edge devices. The platform supports traditional computing with ML inference, delivers push-button deployment and scaling at the edge, and adapts to various frameworks, networks, models, sensors, and modalities. It targets applications from computer vision to generative AI, offering improvements in performance and energy efficiency while enabling easy integration and secure operation for edge deployments.
MMI S.r.l. is an Italian company that specializes in the manufacture and development of advanced micro instruments designed for surgical interventions. Founded in 2015 and based in Calci, Italy, MMI focuses on creating wristed micro instruments and their associated fabrication processes. The company also offers a proprietary robotic platform that enhances the capabilities of these instruments, facilitating complex reconstruction procedures following traumatic injuries and tumor removals in areas such as the breast, head, and bones. MMI aims to support surgeons globally by providing innovative tools that improve surgical outcomes while also reducing costs for patients and healthcare systems.
Axis Bank, established in 1994 and headquartered in Mumbai, India, is the third largest private sector bank in the country. The bank offers a wide range of financial products and services, including personal loans, car loans, savings accounts, credit cards, education loans, trade and forex services, and internet banking. It has expanded its international presence with eight offices located in key global financial centers, including Singapore and Dubai, and a subsidiary in London. These international offices primarily focus on corporate lending, trade finance, syndication, investment banking, and liability businesses. Over the years, Axis Bank has shown consistent growth and stable asset quality, positioning itself as a significant player in the Indian banking sector.
VAST Data
Series E in 2023
VAST Data, Inc. is a technology company that specializes in developing innovative data storage solutions. Headquartered in New York, with additional offices in San Jose, California, the company offers a universal storage platform that utilizes Intel’s Optane SSDs as a cache for data stored on quad-level cell (QLC) SSDs. VAST Data's solutions cater to various sectors, including animation and visual effects, deep learning, life sciences, media and broadcasting, and enterprise backup and recovery. The platform is designed to enhance productivity, streamline data management, and accelerate time-to-insight for workload-intensive applications, making it particularly valuable for AI-driven organizations. Founded in 2016, VAST Data has rapidly established itself as a leading player in the data infrastructure market.
CoreWeave
Secondary Market in 2023
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.
Zomato is a global online platform that combines restaurant discovery, reviews, and food ordering with table reservations. It enables users to search for restaurants, read and write reviews, rate experiences, and order meals for delivery or book a table. The platform connects millions of users with restaurants across multiple countries and provides an ecosystem for partners to engage through advertising. In India, it operates Hyperpure, a program that supplies high-quality ingredients to partner kitchens. Through its integrated services, Zomato aims to simplify dining and food procurement for consumers and support partners with a comprehensive suite of dining and ordering options.
IperionX specializes in producing high-performance titanium alloys using patented metal technologies. The company aims to reduce energy consumption and carbon emissions during production. IperionX owns the Titan Project, a large mineral resource in Tennessee, USA, containing titanium, rare earth elements, silica sand, and zircon.
SHINE
Convertible Note in 2023
SHINE develops and deploys fusion-based technology to produce medical isotopes and neutron sources. Its processes generate molybdenum-99, a precursor to technetium-99m used in diagnostic imaging, and lutetium-177 for diagnostic and therapeutic use, along with iodine-131 and iodine-125 for thyroid treatment and brachytherapy, and xenon-133 for lung and brain imaging. The company’s systems also provide neutron sources for industrial imaging, radiation-effects testing, and fusion materials research. In addition to medical isotopes, SHINE aims to recycle nuclear waste and advance fusion power as a source of clean energy. The business serves health care and industrial customers worldwide. SHINE is based in Janesville, Wisconsin, with an office in Alkmaar, Netherlands.
AgomAb Therapeutics
Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.
Founded in 2020, Evozyne is a biotechnology company specializing in protein design using its data-driven evolution-based molecular engineering platform. Headquartered in Chicago, Illinois, the company focuses on therapeutic discovery and drug development to create novel proteins with advanced functionality.
Generate Biomedicines
Series C in 2023
Generate Biomedicines, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapeutics through its pioneering platform in Generative Biology. Established in 2018, the company utilizes machine learning to analyze existing proteins, enabling it to understand the principles governing the relationship between genetic sequences and protein structure. This approach facilitates the invention of novel antibodies, peptides, enzymes, receptors, and other protein-based therapeutics optimized for specific biological functions. By harnessing its advanced technology, Generate Biomedicines aims to accelerate drug discovery by generating new biological molecules with significant therapeutic potential. Originally known as Generate Biologics, the company adopted its current name in March 2020 to reflect its expanded focus on biomedicine.
Rapport Therapeutics
Series B in 2023
Rapport Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing precision medicines for neurological disorders. The company focuses on creating transformational small-molecule therapies aimed at patients with central nervous system conditions. Leveraging foundational research in neuronal receptor biology, Rapport Therapeutics maps and targets specific neuronal receptor complexes, which are complex assemblies of proteins that include principal receptor subunits and receptor-associated proteins. These receptor-associated proteins are essential for regulating receptor expression and functionality, allowing the company to innovate in the treatment of neurological diseases.
Genesis Therapeutics
Series B in 2023
Founded in 2019, Genesis Therapeutics is a biotechnology company based in South San Francisco, California. It specializes in developing small molecule drug candidates for treating debilitating disorders using artificial intelligence-driven platforms.
GenePlanet
Series B in 2023
GenePlanet is a European biotechnology company that focuses on genetic testing and research. It specializes in preventive and clinical genetic tests designed for individual users and healthcare professionals, respectively. The company's tests are developed in accordance with the highest quality standards and are rooted in current scientific knowledge. GenePlanet's offerings include saliva-based DNA tests that provide personalized insights into diet and lifestyle, enabling individuals to make informed decisions to enhance their health and mitigate potential health risks associated with genetic predispositions. Through its innovative approach, GenePlanet aims to empower individuals to improve their vitality and overall well-being with tailored prevention programs.
Moloco
Secondary Market in 2023
Moloco Inc., founded in 2013 and based in Palo Alto, California, specializes in programmatic advertising solutions aimed at optimizing client acquisition, retention, and monetization strategies. The company offers a cloud-based demand-side platform that leverages machine learning to help businesses of all sizes enhance user acquisition and maximize lifetime value through predictive models. Additionally, Moloco provides a mobile e-commerce platform that supports targeted re-engagement campaigns, allowing application publishers and e-commerce platforms to expand their customer reach more effectively than traditional advertising methods. With a team comprised of top talents from leading tech firms, Moloco is committed to empowering mobile businesses to thrive in a competitive landscape.
Aledade is a health technology and services platform that partners with independent primary care physicians to form and operate Accountable Care Organizations in the United States. It provides data analytics, guided workflows, regulatory and contracting support, payer relationships, and local on-the-ground expertise to help practices transform operations, optimize care delivery, and align incentives around value-based care. The platform integrates care data across the continuum, offers practice management tools, and supports governance and policy guidance to enable autonomous physician groups—from small practices to multispecialty networks and community health centers—to improve patient outcomes while reducing overall costs. Headquartered in Bethesda, Maryland, the company was founded in 2014.
Lightmatter
Series C in 2023
Founded in 2017 and based in Boston, Lightmatter is an artificial intelligence hardware company that specializes in integrated optical technology. It designs photonic chips to enable data processing and communication through light signals, aiming to improve efficiency and scalability for AI data centers.
Saluda Medical
Venture Round in 2023
Saluda Medical is a medical device company specializing in closed-loop neuromodulation therapies for chronic neurological conditions. Founded in 2010 and headquartered in Australia, the company develops innovative devices like Evoke, designed to optimize neural stimulation based on real-time feedback.
Shoobx
Acquisition in 2023
Financing-Ready at Every Turn.
Shoobx is reshaping how private companies get started, raise capital, and exit by raising the bar for cap table management and making venture financing simpler.
Everything You Need to Scale and Exit
- Fundraise faster than ever before
- Have more accurate data and documentation
- Automate your legal operations
Thousands of users, investors, and attorneys rely on Shoobx to get paperwork right the first time and make legal diligence easy and fast.
Automated your next round at shoobx.com.
Asimov designs and develops biologics and gene therapies, focusing on mammalian cell engineering and genetic circuit design. The company combines synthetic biology, computer-aided design, and machine learning to accelerate the design and manufacture of biologics, viral vectors, and cell and gene therapies. Its platform integrates biophysical simulations with data-driven models of biology to engineer genetic circuits and optimize production processes. Founded in 2017 and based in Cambridge, Massachusetts, Asimov supports healthcare firms in advancing therapeutic pipelines through software and engineering tooling that bridges biology and computational design.
Apogee Therapeutics
Series B in 2022
Apogee Therapeutics is a biotechnology company focused on developing therapies for immunological and inflammatory disorders. Based in San Francisco and founded in 2022, it aims to advance novel biologics to address patients’ unmet needs. The company pursues differentiated antibody programs targeting well-established mechanisms implicated in atopic dermatitis, chronic obstructive pulmonary disease, and related inflammatory and immunology indications, supported by antibody engineering to optimize half-life and other properties.
Fanatics
Private Equity Round in 2022
Fanatics is a global sports merchandise company that designs, produces, distributes and retails licensed sports apparel, jerseys and fan gear through online, mobile and physical stores. Founded in 1995 and based in Jacksonville, Florida, the company operates a multi-channel platform that serves professional leagues, teams, media brands, collegiate and professional properties, and retailers, delivering high-quality merchandise to fans with real-time availability across channels.
FogPharma
Series D in 2022
FogPharma is a biotechnology company focused on developing innovative therapies for cancer treatment through its proprietary cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, a leader in drug discovery, the company aims to target cancer-causing proteins within cells that are typically inaccessible to traditional drugs. This novel approach allows for the neutralization of these proteins, potentially transforming the treatment landscape for cancer-related diseases. FogPharma collaborates with leading experts in cancer biology and therapy, fostering a network of researchers, investors, and cancer patients dedicated to advancing its mission. The company is committed to delivering this new class of medicines to improve patient outcomes and enhance quality of life for individuals affected by cancer.
Astera Labs
Series D in 2022
Founded in 2017, Astera Labs is a leading fabless semiconductor company based in Santa Clara, California. It specializes in designing and manufacturing purpose-built connectivity solutions for data-centric systems, focusing on robust PCIe connectivity. The company offers system-aware semiconductor integrated circuits, boards, and services to enhance performance in compute-intensive workloads.
Emalex Biosciences
Series D in 2022
Emalex Biosciences is a biotechnology startup focused on developing innovative treatments for central nervous system (CNS) disorders and rare neurological conditions. Founded in 2018 by Jeff Aronin, the company is advancing its lead candidate, Ecopipam, which has been explored as a potential therapy for various CNS disorders, including pediatric Tourette Syndrome and fluency disorders. Emalex aims to address the needs of patients with rare diseases that currently have limited or no treatment options, collaborating with patient advocacy organizations and medical researchers to facilitate the development of effective biopharmaceutical therapies.
SiMa.ai is a software-centric, embedded edge machine learning system-on-chip company that develops a complete MLSoC platform combining hardware and software to enable high-performance, low-power machine learning inference on embedded edge devices. The platform supports traditional computing with ML inference, delivers push-button deployment and scaling at the edge, and adapts to various frameworks, networks, models, sensors, and modalities. It targets applications from computer vision to generative AI, offering improvements in performance and energy efficiency while enabling easy integration and secure operation for edge deployments.
Local Bounti is an agriculture company based in Hamilton, Montana, focused on controlled environment agriculture. Established in 2018, it specializes in producing and delivering fresh herbs, vegetables, and other products primarily to wholesale restaurant and grocery accounts. The company employs proprietary technology to cultivate leafy greens and herbs in innovative greenhouses, which maintain optimal conditions for growth while using less water and land than traditional farming methods. Local Bounti's products are non-GMO, free from herbicides and pesticides, and are designed to have a longer shelf life and superior taste. By building local facilities operated by local teams, the company aims to serve its communities while minimizing its carbon footprint and environmental impact.
Wasabi Technologies, Inc. is a Boston-based company that offers a cloud storage platform tailored for hybrid and multi-cloud media workflows. Founded in 2016, Wasabi provides hot storage solutions that utilize an Amazon S3 compatible API, enabling organizations to store and access data quickly, with average time-to-first-byte speeds under 15 milliseconds. The company's platform is designed to be simple and affordable, allowing customers to access unlimited data without complex pricing tiers or unpredictable egress fees. Wasabi's services cater to various industries, including media and entertainment, education, scientific research, law enforcement, healthcare, and energy. The company has gained recognition for its rapid growth and innovative approach to cloud storage, serving tens of thousands of customers worldwide.
Galvanize Therapeutics
Series B in 2022
Galvanize Therapeutics develops energy-based medical devices designed to improve biological processes. Its technology uses short-duration, high-voltage electrical pulses to create electric fields that destabilize cells, enabling enhanced healthcare services for patients.
Study Plus
Series D in 2022
Study Plus is an educational application that focuses on enhancing collaborative studying among students. It operates as a learning management platform, helping users adopt a systematic approach to their studies. The platform enables students to record their study times, subjects, and content, while also allowing them to share this information through social networks. By facilitating organization and collaboration, Study Plus aims to support students in completing their syllabus efficiently and effectively.
Aledade is a health technology and services platform that partners with independent primary care physicians to form and operate Accountable Care Organizations in the United States. It provides data analytics, guided workflows, regulatory and contracting support, payer relationships, and local on-the-ground expertise to help practices transform operations, optimize care delivery, and align incentives around value-based care. The platform integrates care data across the continuum, offers practice management tools, and supports governance and policy guidance to enable autonomous physician groups—from small practices to multispecialty networks and community health centers—to improve patient outcomes while reducing overall costs. Headquartered in Bethesda, Maryland, the company was founded in 2014.
SiMa.ai is a software-centric, embedded edge machine learning system-on-chip company that develops a complete MLSoC platform combining hardware and software to enable high-performance, low-power machine learning inference on embedded edge devices. The platform supports traditional computing with ML inference, delivers push-button deployment and scaling at the edge, and adapts to various frameworks, networks, models, sensors, and modalities. It targets applications from computer vision to generative AI, offering improvements in performance and energy efficiency while enabling easy integration and secure operation for edge deployments.
Vention is a cloud-based digital manufacturing platform that enables engineers and manufacturing professionals to design, order, and assemble custom factory equipment in days. It features a 3D Machine Builder with a library of modular structural, motion, and control components, including T-slot aluminum extrusion systems, and supports design, simulation, and ordering directly in a web browser. Its AI-enabled 3D constraints help optimize layouts and ensure feasible configurations, while the platform integrates design, programming, simulation, ordering, and commissioning in a single digital environment. Vention serves both experienced automation specialists and first-time designers, streamlining the creation of automated equipment for applications such as robot cells, tooling, conveyors, and other factory automation.
X (formerly Twitter)
Post in 2022
Twitter is a social networking platform that facilitates the exchange of micro-blogs, known as "tweets," which can be up to 280 characters in length. Launched in 2006, it allows users to send and read tweets through various means, including web browsers, SMS, and mobile applications. With over 400 million monthly visitors and 255 million active users, Twitter serves as a global real-time communications platform. Its diverse user base includes world leaders, athletes, entertainers, and news organizations, contributing to its role as a significant source of information and engagement. The platform is available in more than 35 languages and has a strong presence in major cities worldwide, with headquarters in San Francisco and offices across the United States and internationally.
Castle Creek Biosciences
Venture Round in 2022
Castle Creek Biosciences is a gene therapy company dedicated to developing personalized treatments for rare skin and connective tissue disorders with high unmet medical need. Its approach centers on patient-derived fibroblast cells to create localized cell and gene therapies tailored to each patient's biology, offering options where therapies are limited. The company is headquartered in Exton, Pennsylvania, and was founded in 2015.
Starling Bank
Series D in 2022
Starling Bank Limited is a digital-only bank based in London, United Kingdom, founded in 2014. It specializes in providing personal, joint, and business banking services through a mobile platform. The bank offers a range of financial services, including digital banking, real-time spending intelligence, and personalized banking options. Customers can manage their accounts entirely online, benefiting from features such as same-day payments and comprehensive financial management tools. Starling Bank aims to facilitate a seamless, paperless banking experience for its users.
Beta Technologies
Series B in 2022
Beta Technologies designs and develops electric aircraft and related systems, including propulsion, energy storage, and flight control technologies, with a focus on clean aviation. It builds integrated solutions to enable scalable electric flight, including charging infrastructure and pilot training tools for cargo, medical, passenger, and defense applications, and supports a self-sufficient eVTOL ecosystem that aims to improve access to vertical mobility for logistics and healthcare transport.
Dianthus Therapeutics
Series A in 2022
Dianthus Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for severe autoimmune diseases through targeted therapies. The company's lead candidate, DNTH103, is a monoclonal antibody designed to selectively inhibit a specific component of the immune system, offering potential advantages over existing complement therapies. This treatment aims to improve safety and efficacy for patients suffering from serious autoimmune and inflammatory conditions. Dianthus is committed to advancing its pipeline of next-generation complement therapeutics, supported by a team of experienced professionals in the biotech and pharmaceutical sectors. The company envisions that DNTH103 could be administered as a self-injection for certain patients, enhancing convenience and accessibility in treatment.
Circle
Private Equity Round in 2022
Circle is a Boston-based fintech company founded in 2013 by Jeremy Allaire and Sean Neville. It specializes in utilizing stablecoins for payments, e-commerce, and investment products. Circle's services include Circle Pay for easy money transfers, Circle Invest for crypto asset trading, and Circle Trade for over-the-counter transactions. The company is backed by prominent investors such as Jim Breyer, Goldman Sachs, IDG Capital, General Catalyst, and Accel Partners.
Coin Metrics
Series C in 2022
Founded in 2017, Coin Metrics provides comprehensive crypto financial intelligence. It offers network data, market data, indexes, and risk management solutions to institutions, empowering them with transparent and actionable insights for informed decision-making.
Rapyd
Secondary Market in 2022
Rapyd is a payments platform that integrates fintech services into applications, streamlining access to a variety of local payment methods. It empowers e-commerce merchants, gig platforms, challenger wallets, remittance services, online lenders, and traditional banks to overcome the constraints of outdated infrastructure. By facilitating the creation of innovative, mobile-friendly payment solutions, Rapyd enhances the financial capabilities of its users, allowing them to adapt to the evolving demands of the digital economy.
Starry, Inc. is an innovative internet company based in Boston, Massachusetts, with an additional operation in New York City. Founded in 2014, the company specializes in developing user-friendly Wi-Fi products and high-speed internet services. Its flagship product, Starry Station, is the first ambient touchscreen Wi-Fi router, designed to provide users with enhanced visibility and control over their home networks. In addition to its hardware, Starry employs advanced technologies to deliver high-speed broadband using hybrid-fiber fixed wireless solutions, offering gigabit-capable internet without the constraints of bundles, data caps, or long-term contracts. The company is committed to prioritizing customer needs, ensuring privacy, and promoting affordable connectivity and digital equity within communities.
LifeMine Therapeutics
Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.
PrognomiQ
Venture Round in 2022
PrognomiQ is a technology company focused on transforming early disease detection and treatment through multi-omics data. It generates proteomic, genomic, and metabolomic data to provide insights into complex diseases and to improve patient outcomes. The company develops advanced test products that apply multi-omics data to detect cancers and other conditions earlier, complementing traditional diagnostics and supporting monitoring of disease recurrence. By integrating proteomic data with broader health data, PrognomiQ aims to enable clinicians to diagnose more accurately and tailor interventions, ultimately advancing preventive and precision medicine.
Menlo Micro
Series C in 2022
Menlo Micro, Inc. specializes in the design and development of electronic switches, particularly through its innovative Ideal Switch technology. This electromechanical switch is capable of handling both AC/DC and RF signals, making it suitable for a range of applications including high-power tunable resonators, filters, broadband power amplifier impedance matching, and electronically steerable antennas. The company's products are utilized in various industries, such as battery management, home automation, electronic vehicles, medical instrumentation, and the industrial Internet of Things, as well as in next generation 5G mobile networks. Founded in 2016 and headquartered in Irvine, California, Menlo Micro aims to enhance the efficiency and performance of advanced systems under high-stress conditions.
Saluda Medical
Private Equity Round in 2022
Saluda Medical is a medical device company specializing in closed-loop neuromodulation therapies for chronic neurological conditions. Founded in 2010 and headquartered in Australia, the company develops innovative devices like Evoke, designed to optimize neural stimulation based on real-time feedback.
Gousto
Secondary Market in 2022
Gousto is a meal‑kit company that delivers pre‑measured ingredients and recipe cards to customers’ homes each week. The service offers a wide range of dishes, including vegetarian, vegan, gluten‑free and dairy‑free options, and focuses on fresh, organic, seasonal produce. Recipes are created by professional chefs and tested by a community of food enthusiasts to ensure quality and variety. Customers select weekly menus online and can pause or hold their subscription when needed. Founded in 2011 by Timo and James, Gousto has grown from market stall offerings to a full‑service platform that aims to simplify cooking, reduce food waste, and provide convenient, healthy meal options for busy households.
Omada Health
Series E in 2022
Omada Health is a digital healthcare company that offers personalized programs to manage chronic conditions such as prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health. It combines professional coaching, connected devices, real-time data, and personalized feedback to deliver clinically meaningful results.
Somatus, Inc. is a healthcare company focused on providing specialized kidney care services aimed at delaying or preventing the progression of chronic kidney disease. Founded in 2016 and headquartered in McLean, Virginia, Somatus collaborates with health plans, health systems, nephrology, and primary care groups to deliver integrated care for patients with or at risk of kidney disease. Its comprehensive services include home hemodialysis, peritoneal dialysis, in-center hemodialysis, kidney transplant, and conservative care. By utilizing vertically integrated clinical services and technology, Somatus seeks to improve patient outcomes, enhance care coordination, and promote the use of home dialysis modalities while increasing the rates of kidney transplantation. The company's mission is to ensure that patients can access the care they need to manage kidney disease effectively.
CelLink designs and manufactures high-conductance, large-area flexible circuits and backplanes for power electronics and solar applications. The company develops flexible conductive backplanes that integrate busing, fusing, voltage and temperature monitoring into a single circuit, enabling efficient power and data transmission. Based in Belmont, California, CelLink serves applications including batteries, LEDs, wire harnessing, and solar cells, aiming to provide reliable, scalable power-management solutions at an affordable price.
Chenjing Tech
Series A in 2022
VR
LeddarTech
Series D in 2022
LeddarTech develops advanced detection and ranging systems using infrared LEDs and algorithms. It offers off-the-shelf smart sensor modules for various applications such as traffic management, autonomous vehicles, smart homes, and agriculture. The company provides interconnected sensor solutions for infrastructure, pollution monitoring, mobility, and traffic management in cities.
MNTN is a technology company specializing in Connected TV advertising. It offers advanced targeting, measurement, and automated optimization tools to deliver effective performance-driven campaigns for businesses.
Capital Markets Gateway
Series B in 2022
Capital Markets Gateway Inc. is a financial technology firm that specializes in modernizing the equity capital markets. Based in Chicago, Illinois, with additional locations in New York and Seattle, CMG offers a platform that provides real-time information and analytics to investors, underwriters, and issuers. Founded in 2015 and officially launched in 2017 by a team of experienced professionals, the platform enhances transparency and workflow efficiencies in capital raising activities. It enables users to monitor the capital raising landscape, conduct due diligence, and make informed investment decisions while facilitating collaboration between stakeholders. Currently, CMG's platform is utilized by over 100 buy-side firms and 10 investment banks, supporting a substantial amount of assets under management.
Sonder is a hospitality company that designs, selects, and directly manages a portfolio of apartment-style accommodations, including rooms, suites, apartments, and boutique hotel properties, for short- and long-term stays. It operates in more than 30 cities across eight countries and three continents, with each property chosen, designed, and managed by the company. The business blends well-designed spaces with a technology-driven service model, supported by a mobile app that enables self-service features and 24/7 on-the-ground support. By offering flexible stays such as month-to-month arrangements, Sonder delivers modern, consistent experiences across diverse locations.
Bolt Technology OÜ is a transportation platform based in Tallinn, Estonia, that provides ride-hailing, micromobility, and food delivery services. Founded in 2013, Bolt operates a smartphone application that allows users to book taxis directly, selecting options based on price and quality ratings, while also tracking the driver's arrival in real time. The platform aims to enhance urban mobility by offering a reliable and accessible alternative to traditional transportation methods, contributing to reduced traffic congestion and pollution in cities. With over 50 million customers across more than 40 countries, Bolt is recognized as one of the fastest-growing startups globally, striving to create a future with less reliance on car ownership.
Oddity
Venture Round in 2022
ODDITY is a consumer-tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company owns IL MAKIAGE and SpoiledChild.
SalioGen Therapeutics
Series B in 2022
SalioGen Therapeutics develops curative therapies for inherited disorders using its Exact DNA Integration Technology (EDIT) platform. EDIT employs proprietary mammal-derived enzymes called Saliogase, enabling non-viral delivery of genes of any size and offering significant manufacturing advantages.
DNA Script
Series C in 2022
DNA Script is a Paris-based company that develops synthetic biology tools focused on DNA synthesis. It employs enzymatic processes to produce synthetic nucleic acids, including oligonucleotides, enabling genomics and molecular biology applications. Founded in 2014, it introduced the SYNTAX benchtop DNA printer to provide labs with greater workflow control and faster access to results. By producing DNA through natural enzymes, the company aims to accelerate research and the development of new therapeutics.
Asoview is an online booking platform that specializes in facilitating reservations for a diverse range of tourist activities and experiences. The company's services encompass various options, including water and motorsports, sightseeing tours, horse trekking, cooking classes, and cultural activities. By providing a comprehensive and user-friendly interface, Asoview enables customers to easily discover and book activities that match their interests, streamlining the planning process for travelers and enhancing their overall experience.
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.
Cvent is a technology provider focused on enhancing the meetings, events, and hospitality industries through a comprehensive event marketing and management platform. The company offers software solutions that facilitate online event registration, venue selection, event marketing, and management, as well as attendee engagement for various formats, including virtual, hybrid, and onsite events. Cvent's tools are designed to help event planners and marketers optimize the revenue potential of their programs while simplifying the management of each stage in the event lifecycle. By integrating these functionalities, Cvent aims to streamline the planning process and improve overall event effectiveness.
P3 Health Partners
Post in 2021
P3 Health Partners is a patient-centered and physician-led population health management company based in Henderson, Nevada. Founded in 2017, P3 focuses on providing primary health care services through clinical operations, population health management, and consulting. The company is dedicated to enhancing patient outcomes and experiences by leveraging a coordinated network of community providers. By integrating existing healthcare resources, P3 aims to improve care delivery while reducing costs. The organization comprises a team of doctors, clinicians, and support professionals who are committed to delivering value-based care, ensuring greater satisfaction for both patients and healthcare providers.
Local Bounti is an agriculture company based in Hamilton, Montana, focused on controlled environment agriculture. Established in 2018, it specializes in producing and delivering fresh herbs, vegetables, and other products primarily to wholesale restaurant and grocery accounts. The company employs proprietary technology to cultivate leafy greens and herbs in innovative greenhouses, which maintain optimal conditions for growth while using less water and land than traditional farming methods. Local Bounti's products are non-GMO, free from herbicides and pesticides, and are designed to have a longer shelf life and superior taste. By building local facilities operated by local teams, the company aims to serve its communities while minimizing its carbon footprint and environmental impact.
Grab is a Southeast Asia-based mobile platform that integrates ride-hailing, food and grocery delivery, and financial services, connecting drivers, merchants, and customers through a single app. It operates in Singapore, Indonesia, the Philippines, Malaysia, Thailand, Vietnam, and Myanmar, and holds a leading market share in ride-hailing and food delivery, with 89% of revenue derived from these core businesses. The company also offers payments, consumer loans, and enterprise financial services. It charges commissions to both riders and merchants as it links them with consumers. Founded in 2012 by Anthony Tan and Tan Hooi Ling, Grab is headquartered in Singapore and maintains offices in Seattle, Beijing, Bangalore, Jakarta, and Vietnam. In 2024, Singapore, Indonesia, and Malaysia together contributed more than 70% of revenue.
Innovid is an independent omni-channel advertising and analytics platform designed specifically for television. The company offers a comprehensive software solution that enables advertisers to personalize, deliver, and measure innovative advertising experiences across various devices and media outlets. Its services encompass ad serving, measurement, and creative optimization for TV advertisements, catering to advertisers, publishers, and media agencies. With a strong presence in the U.S., Canada, EMEA, APAC, and LATAM, Innovid focuses on enhancing the effectiveness of TV advertising by providing tools that facilitate the creation and analysis of ads in connected TV, mobile TV, and desktop environments.
Quell Therapeutics
Series B in 2021
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.
Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cell engineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.
GaN Systems
Venture Round in 2021
GaN Systems develops and manufactures gallium nitride power switching transistors for various applications. Its products include 650 V E-HEMT and 100 V E-HEMT transistors, serving consumer brand and enterprise equipment manufacturers globally.